RightFit Trial Directory

Parkinson's Disease clinical trials in Minneapolis, MN

22 recruiting parkinson's disease studies with a site in Minneapolis, MN.

All trials in Minneapolis, MN · All Parkinson's Disease trials

RecruitingPhase 3NCT06170788

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Sponsor: Merck Sharp & Dohme LLC

Minneapolis, MN · Rochester, MN · +13 more sites

RecruitingPhase 3NCT06841354

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Sponsor: Merck Sharp & Dohme LLC

Minneapolis, MN · +38 more sites

RecruitingPhase 3NCT06952504

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Sponsor: Merck Sharp & Dohme LLC

Minneapolis, MN · +52 more sites

RecruitingPhase 3NCT06989112

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Sponsor: AstraZeneca

Marshall, MN · Minneapolis, MN · Rochester, MN · +60 more sites

RecruitingPhase 2NCT06996652

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

Sponsor: Yale University

Minneapolis, MN · +17 more sites

RecruitingPhase not listedNCT06405334

Kinematic and Neural Dynamics of Postural Instability in Parkinson's Disease

Sponsor: VA Office of Research and Development

Minneapolis, MN

RecruitingEarly Phase 1NCT07835308

Bayesian Optimization of DBS for Gait

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingPhase 4NCT04373317

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Sponsor: VA Office of Research and Development

Minneapolis, MN · +23 more sites

RecruitingPhase not listedNCT06464029

Pathways Mediating Impaired Postural Control in Parkinson's Disease

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingNot applicableNCT06998303

Imaging Core Aim 2, and Udall Project 2 Aim 2

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingEarly Phase 1NCT05893186

Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingNot applicableNCT05934747

Aim 3 Particle Swarm Optimization PIGD

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingPhase not listedNCT05568199

Udall Project 1 Aim 4

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingNot applicableNCT06506058

Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingNot applicableNCT06692920

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingPhase not listedNCT05656586

Udall Project 2 Aim 2A&C

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingNot applicableNCT05962489

Sleep-specific DBS Therapy in Parkinson's Disease

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingNot applicableNCT06848205

Percept Transitions in FOG and PD

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingNot applicableNCT07226284

Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingNot applicableNCT05557864

Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease

Sponsor: University of Minnesota

Minneapolis, MN

RecruitingPhase not listedNCT05658302

Circuit-Based Deep Brain Stimulation for Parkinson's Disease P1A2&3 Catalyst

Sponsor: University of Minnesota

Minneapolis, MN

Not yet recruitingPhase 1 / Phase 2NCT07709741

Sustained Release Oral Formulation For Treatment Of Parkinsons Disease

Sponsor: University of Minnesota

Minneapolis, MN

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.